Literature DB >> 1425913

Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine.

P G Kremsner1, S Neifer, M F Chaves, R Rudolph, U Bienzle.   

Abstract

A combination therapy was tested consisting of chloroquine and interferon-gamma (IFN-gamma) in the late phase of blood-stage Plasmodium vinckei malaria in BALB/c mice. When mice were treated with three times 300 micrograms chloroquine at 24-h intervals starting at a parasitemia of 30%-50%, only 5 of 14 mice (36%) died 2-4 days after initiation of therapy. However, when infected mice received chloroquine plus 1 microgram IFN-gamma at the same time, 14 of 18 mice (78%) died 0.5-3 days after start of therapy (p < 0.05) despite clearance of parasitemia. The histopathology from mice dying after combination therapy revealed interstitial leukocyte infiltration of lung tissue, severe liver cell necrosis and kidney tubular necrosis. Pretreatment of P. vinckei-infected mice with pentoxifylline, a phosphodiesterase inhibitor, led to a significant decrease of IFN-gamma-induced lethality (p < 0.05). In contrast, pretreatment with neutralizing antibodies to tumor necrosis factor or with L-N-monomethyl arginine, the latter an inhibitor of the nitric oxide synthase, significantly increased lethality (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425913     DOI: 10.1002/eji.1830221118

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria.

Authors:  D J Perkins; P G Kremsner; D Schmid; M A Misukonis; M A Kelly; J B Weinberg
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Pentoxifylline attenuates ischemia/reperfusion injury to the small intestine in the rat.

Authors:  R Udassin; A Vromen; D Seror; Y Haskel
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

3.  Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria.

Authors:  M S Rhee; B D Akanmori; M Waterfall; E M Riley
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 4.  Experimental Models to Study the Pathogenesis of Malaria-Associated Acute Respiratory Distress Syndrome.

Authors:  Samantha Yee Teng Nguee; José Wandilson Barboza Duarte Júnior; Sabrina Epiphanio; Laurent Rénia; Carla Claser
Journal:  Front Cell Infect Microbiol       Date:  2022-05-23       Impact factor: 6.073

Review 5.  Cross-talk between nitric oxide and transforming growth factor-beta1 in malaria.

Authors:  Yoram Vodovotz; Ruben Zamora; Matthew J Lieber; Shirley Luckhart
Journal:  Curr Mol Med       Date:  2004-11       Impact factor: 2.222

6.  Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice.

Authors:  H Perlmann; S Kumar; J M Vinetz; M Kullberg; L H Miller; P Perlmann
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria.

Authors:  P G Kremsner; A Nüssler; S Neifer; M F Chaves; U Bienzle; G Senaldi; G E Grau
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

8.  Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production.

Authors:  C W Roberts; S M Cruickshank; J Alexander
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

9.  Transforming growth factor beta production is inversely correlated with severity of murine malaria infection.

Authors:  F M Omer; E M Riley
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

10.  Tim-3 signaling blockade with α-lactose induces compensatory TIGIT expression in Plasmodium berghei ANKA-infected mice.

Authors:  Yiwei Zhang; Ning Jiang; Ting Zhang; Ran Chen; Ying Feng; Xiaoyu Sang; Na Yang; Qijun Chen
Journal:  Parasit Vectors       Date:  2019-11-11       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.